Advanced Tissue Sciences

From IntactiWiki
Revision as of 03:08, 10 February 2020 by WikiModEn2 (talk | contribs) (Insert SEEALSO section.)
Jump to navigation Jump to search

Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision.[1] They are also the makers of NouriCel, another product made from harvested foreskins,[2] and one of the main ingredients of SkinMedica's TNS Recovery Complex product.[3]

Earnings

Dermagraft-TC is FDA approved,[4][5] and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.[6]

Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.[7]

In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.[8]

See also

References

  1. ↑   Dermagraft-TC: Overview, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
    Quote: Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  2. ↑   The Foreskin Mafia, Acroposthion.com. Retrieved 6 March 2011.
    Quote: TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
  3. ↑   (12 February 2002). SkinMedica Introduces TNS Recovery Complex, SkinMedica. Retrieved 6 March 2011.
    Quote: TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
  4. ↑   (2011). Dermagraft-TC: General Information: Advanced Tissue Sciences, MediLexicon International Ltd. Retrieved 7 May 2011.
    Quote: Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  5. ↑   (28 March 1997). Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA, HighBeam Research. Retrieved 7 May 2011.
    Quote: the Food and Drug Administration has approved Dermagraft-TC
  6. ↑ Circumcision. Daecher M. Icon 1998;2(2):70-3.
  7. ↑   Pitta, Julie: Biosynthetics. Forbes. Pp. 170-171.
    Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
  8. ↑   Hall, C.T.. Biotech's Big Discovery. San Francisco Chronicle. 25 October 1996; : E1, E4.
Retrieved from "https://en.intactiwiki.org/w/index.php?title=Advanced_Tissue_Sciences&oldid=11844"